DDAH2 Antikörper (N-Term)
-
- Target Alle DDAH2 Antikörper anzeigen
- DDAH2 (Dimethylarginine Dimethylaminohydrolase 2 (DDAH2))
-
Bindungsspezifität
- N-Term
- Reaktivität
- Human, Maus, Ratte, Hund, Pferd, Kaninchen, Rind (Kuh)
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DDAH2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- MGTPGEGLGR CSHALIRGVP ESLASGEGAG AGLPALDLAK AQREHGVLGG
- Homologie
- Cow: 93%, Dog: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 79%, Rat: 100%
- Produktmerkmale
- This is a rabbit polyclonal antibody against DDAH2. It was validated on Western Blot using a cell lysate as a positive control.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human DDAH2
- Top Product
- Discover our top product DDAH2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 285 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Management of Intrathecal Catheter-Tip Inflammatory Masses: An Updated 2007 Consensus Statement From An Expert Panel." in: Neuromodulation : journal of the International Neuromodulation Society, Vol. 11, Issue 2, pp. 77-91, (2011) (PubMed).
: "
-
Management of Intrathecal Catheter-Tip Inflammatory Masses: An Updated 2007 Consensus Statement From An Expert Panel." in: Neuromodulation : journal of the International Neuromodulation Society, Vol. 11, Issue 2, pp. 77-91, (2011) (PubMed).
-
- Target
- DDAH2 (Dimethylarginine Dimethylaminohydrolase 2 (DDAH2))
- Andere Bezeichnung
- DDAH2 (DDAH2 Produkte)
- Synonyme
- ddah2 antikoerper, MGC84290 antikoerper, g6a antikoerper, ddah antikoerper, ng30 antikoerper, ddahii antikoerper, MGC89103 antikoerper, DDAH2 antikoerper, DDAH antikoerper, DDAHII antikoerper, G6a antikoerper, NG30 antikoerper, 1110003M04Rik antikoerper, AU019324 antikoerper, AW413173 antikoerper, DDAH-2 antikoerper, Ddah antikoerper, dimethylarginine dimethylaminohydrolase 2 antikoerper, dimethylarginine dimethylaminohydrolase 2 L homeolog antikoerper, ddah2 antikoerper, ddah2.L antikoerper, DDAH2 antikoerper, Ddah2 antikoerper
- Hintergrund
-
DDAH2 hydrolyzes N(G),N(G)-dimethyl-L-arginine (ADMA) and N(G)-monomethyl-L-arginine (MMA) which act as inhibitors of NOS. DDAH2 has therefore a role in nitric oxide generation.This gene belongs to the dimethylarginine dimethylaminohydrolase (DDAH) gene family. The encoded enzyme plays a role in nitric oxide generation by regulating cellular concentrations of methylarginines, which in turn inhibit nitric oxide synthase activity. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: DDAH, DDAHII, G6a, NG30
Protein Interaction Partner: VAC14, UBC, TRIP13, VCAM1, FN1, CDC73, TAF1D, ZAK, DNAJB11, GADD45G, RPS6KA5, TSC22D1, TNFSF11, MKNK1, TK1, STK3, SMN1, RPS6KA1, RAP1B, PIN1, RCC1, CDKN1A, CDK4, ATP1B1, ANXA7,
Protein Size: 285 - Molekulargewicht
- 31 kDa
- Gen-ID
- 23564
- NCBI Accession
- NM_013974, NP_039268
- UniProt
- O95865
-